Extended Data Fig. 2: Pie charts of histologic subsets of histiocytoses analyzed with kinase mutations identified in each subset.
From: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
(a) Numbers and percentage of patients with each histological subtype of histiocytosis sequenced in this study. Frequency of kinase mutations in the subset of patients with (b) Erdheim-Chester Disease, (c) Langerhans Cell Histiocytosis, (d) Juvenile Xanthogranuloma, (e) Rosai-Dorfman Disease, and (f) Histiocytic Sarcoma.
